日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Preclinical Characterization of Relatlimab, a Human LAG-3-Blocking Antibody, Alone or in Combination with Nivolumab

人类 LAG-3 阻断抗体 Relatlimab 单独或与 Nivolumab 联合使用的临床前表征

Kent Thudium #, Mark Selby #, Julie A Zorn #, Gregory Rak #, Xi-Tao Wang, Roderick Todd Bunch, Jason M Hogan, Pavel Strop #, Alan J Korman #

Impact of Drug Conjugation on Thermal and Metabolic Stabilities of Aglycosylated and N-Glycosylated Antibodies

药物结合对非糖基化和N-糖基化抗体的热和代谢稳定性的影响

Sayumi Yamazoe, Srikanth Kotapati, Jason M Hogan, Sean M West, Xiaodi A Deng, S J Diong, Jaren Arbanas, Thien Anh Nguyen, Aarti Jashnani, Diksha Gupta, Arvind Rajpal, Gavin Dollinger, Pavel Strop

Antibody blockade of CD96 by distinct molecular mechanisms

抗体通过不同的分子机制阻断 CD96

Peter S Lee, Bryant Chau, Ishita Barman, Christine Bee, Aarti Jashnani, Jason M Hogan, Barbara Aguilar, Gavin Dollinger, Arvind Rajpal, Pavel Strop

Design and characterization of mouse IgG1 and IgG2a bispecific antibodies for use in syngeneic models

设计和表征用于同基因模型的鼠IgG1和IgG2a双特异性抗体

Feng Wang ,Jordan C Tsai ,Jonathan H Davis ,Bryant Chau ,Jia Dong ,Sean M West ,Jason M Hogan ,Matthew L Wheeler ,Christine Bee ,Winse Morishige ,Thomas Cayton ,Donata David-Brown ,Chengyue Zhang ,Alexander Kozhich ,Tim Sproul ,Gavin Dollinger ,Arvind Rajpal ,Pavel Strop

Renal Survival in Patients with Collapsing Compared with Not Otherwise Specified FSGS

与未另行规定的局灶节段性肾小球硬化症(FSGS)患者相比,塌陷型FSGS患者的肾脏生存率

Laurin, Louis-Philippe; Gasim, Adil M; Derebail, Vimal K; McGregor, JulieAnne G; Kidd, Jason M; Hogan, Susan L; Poulton, Caroline J; Detwiler, Randal K; Jennette, J Charles; Falk, Ronald J; Nachman, Patrick H

The development of an integrated platform to identify breast cancer glycoproteome changes in human serum

开发用于识别人类血清中乳腺癌糖蛋白质组变化的综合平台

Zhi Zeng, Marina Hincapie, Brian B Haab, Samir Hanash, Sharon J Pitteri, Steven Kluck, Jason M Hogan, Jacob Kennedy, William S Hancock